CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
Open Access
- 21 June 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 9 (9) , 1098-1108
Abstract
The role of B cells in antitumor immunity and their impact on emerging immunotherapies is increasingly gaining attention. B-cell effector functions include not only secretion of antibodies, but also presentation of antigens to T cells. A physiologic B-cell subset with immunostimulatory properties was described in humans, defined by a high expression of CD86 and downregulation of CD21. We used multicolor flow cytometry and IHC to elucidate abundance and spatial distribution of these antigen-presenting B cells (BAPC) in blood (peripheral blood mononuclear cells, PBMC) and tumor samples of 237 patients with cancer. Antigen-specific T-cell responses to cancer testis antigens were determined using tetramer staining and sorted BAPCs in FluoroSpot assays for selected patients. We found that BAPCs were increased in the tumor microenvironment of 9 of 10 analyzed cancer types with site-specific variation. BAPCs were not increased in renal cell carcinoma, whereas we found a systemic increase with elevated fractions in tumor-infiltrating lymphocytes (TIL) and PBMCs of patients with colorectal cancer and gastroesophageal adenocarcinoma. BAPCs were localized in lymphoid follicles of tertiary lymphoid structures (TLS) and were enriched in tumors with increased numbers of TLSs. BAPCs isolated from tumor-draining lymph nodes of patients with cancer showed increased percentages of tumor antigen–specific B cells and induced responses of autologous T cells in vitro. Our results highlight the relevance of BAPCs as professional antigen-presenting cells in tumor immunity and provide a mechanistic rationale for the observed correlation of B-cell abundance and response to immune checkpoint inhibition.Keywords
All Related Versions
Funding Information
- German Cancer Aid (70113702, 70113009)
- Center for Molecular Medicine Cologne
- German Research Foundation (325827080)
- European Union Regional Fund for Development (0801306)
This publication has 40 references indexed in Scilit:
- Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinomaBMC Clinical Pathology, 2014
- B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal CancerPLOS ONE, 2014
- Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain LineagesJournal of Virology, 2014
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian CancerClinical Cancer Research, 2012
- Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimersNature Protocols, 2012
- Suppression of tumour-specific CD4 + T cells by regulatory T cells is associated with progression of human colorectal cancerGut, 2011
- Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabProceedings of the National Academy of Sciences, 2011
- Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimersNature Methods, 2009
- Complement receptors CD21 and CD35 in humoral immunityImmunological Reviews, 2007
- Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T‐cell immunity in vivoImmunology, 2005